Abstract:their therapeutic potential in CLC has not been determined.Here, we identified that miR-410 is involved in CLC development through direct regulation of the X-linked inhibitor of apoptosis (XIAP).Methods: A microRNA library (810 microRNAs) was transfected in TFK CLC cells and cell viability was measured 48h later by a CellTiter-Glo assay.MicroRNA array analysis was performed in 22 human CLCs and 12 normal human cholangiocytes MiR-410 was overexpressed (20nM) in TFK cells and soft-agar colony and matrigel invasion assays were performed.MiR-410 was overexpressed in TFK CLC cells or suppressed (20nM) in H69 non-malignant cholangiocytes and their ability to form colonies in soft-agar was tested 20 days later.5x106 TFK cells were injected subcutaneously in nude mice and when tumors reached 100mm3 size, the mice were randomly distributed in groups: untreated, treated with miR-410 (2mg/kg), treated with sorafenib (20mg/kg), treated with miR-410 and sorafenib.All treatments were repeated for 4 cycles every 5 days and tumor size was measured in a daily basis.Results: The microRNA screen revealed that miR-410 suppressed effectively (72%) the growth of TFK cholangiocarcinoma cells.Furthermore, microRNA array analysis in 22 human cholangiocarcinomas and 12 normal human cholangiocytes revealed that miR-410 was highly (9.1-fold) down-regulated in CLCs relative to normal cholangiocytes.Overexpression of miR-410 suppressed (82%) the colony formation ability and invasiveness (6.6-fold) of TFK cells.On the other hand, inhibition of miR-410, by an antisense-microRNA against miR-410, transformed H69 non-malignant cholangiocytes.Bioinformatic analysis revealed that miR-410 has a binding site in the 3'UTR of XIAP gene.MiR-410 overexpression inhibited 72% XIAP luciferase activity and 7.1-fold XIAP mRNA levels in TFK cells.MiR-410 was found down-regulated and XIAP was found up-regulated in 12/22 (54.5%) human CLCs suggesting their human relevance.Overexpression of miR-410 suppressed 64% while sorafenib suppressed 38% the growth of TFK xenograft tumors in mice.Combinatorial treatment with miR-410 and sorafenib suppressed more effectively (88%) TFK tumor growth.Conclusion: We have identified that the miR-410/XIAP pathway is important for the transformation of human cholangiocytes and miR-410 treatment as a monotherapy or in combination with sorafenib suppresses CLC tumor growth in mice, suggesting its therapeutic potential for CLC patients.1050

Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene.

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

Function of Microrna-145 and Mechanisms Underlying Its Role in Malignant Tumor Diagnosis and Treatment

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells.

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer

MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.

Biology of Human Tumors miR-2045 p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB 22 A

Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

MicroRNA-185 suppresses growth and invasion of colon cancer cells through inhibition of the hypoxia‑inducible factor-2α pathway in vitro and in vivo.

Microrna-485-5p Functions As a Tumor Suppressor in Colorectal Cancer Cells by Targeting CD147

Interaction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells

MicroRNA-181a Promotes Tumor Growth and Liver Metastasis in Colorectal Cancer by Targeting the Tumor Suppressor WIF-1

FLI-1 mediates tumor suppressor function via Klotho signaling in regulating CRC

MiR-145 Regulates PAK4 Via the MAPK Pathway and Exhibits an Antitumor Effect in Human Colon Cells.

miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.

MicroRNA-204 modulates colorectal cancer cell sensitivity in response to 5-fluorouracil-based treatment by targeting high mobility group protein A2

1052 MicroRNA-218 Inhibits Cell Cycle Progression and Promotes Apoptosis in Colon Cancer Cells by Downregulating Oncogene BMI1